Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent Platinum Resistant Ovarian Cancer 1Rectal Neoplasms 1Neoplasm Metastasis 1Carcinoma 1Adenoviridae Infections 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × enadenotucirev × Clear all
NCT03916510 2025-02-06

CEDAR

University of Oxford

Phase 1 Completed
12 enrolled 13 charts
Gastrointestinal

Adenoviridae Infections, Rectal Neoplasms

NCT02636036 2021-11-09

SPICE

Akamis Bio

Phase 1 Completed
51 enrolled
GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT02028117 2021-05-13

OCTAVE

Akamis Bio

Phase 1 Completed
38 enrolled
Gynecologic

Recurrent Platinum Resistant Ovarian Cancer

NCT02028442 2020-03-12

EVOLVE

Akamis Bio

Phase 1/2 Completed
61 enrolled
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡